Picard Medical is trading 5.1% down at $9.30, reversing part of its sharp advance amid unusually volatile trading.
- The stock rose from $3.21 on August 21, 2026, to $9.80 on August 26, 2026.
- No August 27 company-specific announcement was identified; the latest major catalyst is the August 19 second-quarter report: approximately $2.95 million in revenue versus roughly $1.55 million expected.
- The broader market is modestly higher, so market-wide weakness does not clearly explain the decline; the immediate cause remains unconfirmed.